Latest Share Chat

REMOVE ADS

Hutchmed Share News (HCM)

Hutchmed Information

Share Price Information for Hutchmed (HCM)

Share Price is delayed by 15 minutes

Get Live Data

168.00 3.25 (1.97%)

Bid:

158.00

Ask:

162.00

Spread: 4.00 (2.532%)

Market Cap: £1.44b

Last checked at -

Intraday Hutchmed Share Chart

REMOVE ADS

Hutchmed News

Hutchmed to get payment from Takeda as Fruzaqla launched in Japan

(Alliance News) - Hutchmed (China) Ltd on Friday said it will receive a milestone payment from Takeda Pharmaceutical Co Ltd after Takeda launched Hutc...

Hutchmed China receives first milestone payment for Takeda drug sales

(Alliance News) - Hutchmed (China) Ltd on Thursday said it will receive a USD20 million payment from its partner Takeda Pharmaceutical Co Ltd which ac...

Hutchmed to receive $20m Fruzaqla milestone payment

(Sharecast News) - Hutchmed China announced on Thursday that it was set to receive a $20m milestone payment from its partner Takeda, after sales of 'F...

Hutchmed reports positive results from AstraZeneca lung cancer collaboration

(Sharecast News) - Hutchmed China announced positive results from its Savannah phase two trial on Wednesday, which studied the combination of 'Tagriss...

TOP NEWS: AstraZeneca's Tagrisso plus Orpathys shows promising results

(Alliance News) - Hutchmed China Ltd on Wednesday said that Tagrisso plus Orpathys showed a high clinically meaningful response rate in patients with ...

AIM WINNERS & LOSERS: Windward rises; Hutchmed recovers

(Alliance News) - The following stocks are the leading risers and fallers on AIM on Thursday.

Hutchmed partner Takeda gets Japanese approval for Fruzaqla

(Sharecast News) - Hutchmed China announced on Tuesday that its partner Takeda has received approval from the Japanese Ministry of Health, Labour and ...

Takeda Pharmaceutical says Fruzaqla cancer drug gets Japan backing

(Alliance News) - Takeda Pharmaceutical Co Ltd on Tuesday said it landed an approval for its Fruzaqla drug in Japan.